Concentrated methotrexate solutions
AssigneeMedac Gesellschaft Fuer Klinische Spezialpraeparate Mbh
InventorHeiner Will
Life of this patent
Estimating the term…
Abstract
Concentrated methotrexate solutions are described which are suitable for the use of an active substance in the production of a parenterally administered medicament for the treatment of inflammatory autoimmune diseases. The methotrexate is added to a pharmaceutically acceptable solvent at a concentration of more than 25 mg/ml. The invention also relates to a ready-made syringe and a carpule containing such a pharmaceutical solution formulation, as well as a pen injector comprising such a carpule and/or a ready-made syringe.
Claims20
A ready-made syringe, comprising a pharmaceutical solution formulation of methotexate with a concentration of more than 30 mg/ml in a pharmaceutically acceptable solvent for subcutaneous administration.
A carpule, comprising a pharmaceutical solution formulation of methotrexate with a concentration of more 30 mg/ml in a pharmaceutically acceptable solvent for subcutaneous administration.
Dependencies are inferred from the claim text.